• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry Product Image

Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

  • ID: 2080118
  • March 2012
  • Region: Global
  • 153 Pages
  • iCD Research

FEATURED COMPANIES

  • Abbott
  • Bing
  • Flickr.
  • Matrix Lab
  • Piramal Healthcare
  • Sinopharm
  • MORE

“Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how Pharmaceutical industry suppliers’ media spend, marketing and sales strategies and business practices are set to change 2012–2013. This report gives you access to the media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading suppliers. The report also identifies future growth of buyers and suppliers, M&A and investment expectations. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes.

Synopsis:

- This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.
- The research is READ MORE >

FEATURED COMPANIES

  • Abbott
  • Bing
  • Flickr.
  • Matrix Lab
  • Piramal Healthcare
  • Sinopharm
  • MORE

1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Executive Summary
3 Global Pharmaceutical Industry Dynamics
3.1 Revenue Growth Expectations in the Global Pharmaceutical Industry
3.1.1 Global pharmaceutical industry: revenue growth expectations by company type
3.1.2 Global pharmaceutical industry: revenue growth expectations by region
3.1.3 Global pharmaceutical industry: revenue growth expectations by turnover
3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
3.1.5 Global pharmaceutical industry: Revenue growth expectations-cross industry comparisons
3.2 Future Developments in Business Structure: Global Pharmaceutical Industry
3.2.1 Global pharmaceutical industry: future developments by buyers
3.2.2 Global pharmaceutical industry: future developments by suppliers
3.2.3 Global pharmaceutical industry: future developments by region
3.2.4 Global pharmaceutical industry: future developments by company turnover
3.3 M&A Activity Projections in the Global Pharmaceutical Industry
3.3.1 M&A activity projections in the global pharmaceutical industry by buyers
3.3.2 M&A activity projections in the global pharmaceutical industry by suppliers
3.3.3 M&A activity projections in the global pharmaceutical industry by region
3.3.4 M&A activity projections in the global pharmaceutical industry by company turnover
3.3.5 Global pharmaceutical industry: expansion abroad vs M&A activity projections
3.4 Capital Expenditure Forecast in the Global Pharmaceutical Industry
3.4.1 Capital expenditure forecast in the global pharmaceutical industry by buyers
3.4.2 Capital expenditure forecast in the global pharmaceutical industry by suppliers
3.4.3 Capital expenditure forecast in the global pharmaceutical industry by region
3.4.4 Capital expenditure forecast in the global pharmaceutical industry by company turnover
3.5 Planned Change in Staff Recruitment Activity: Global Pharmaceutical Industry
3.5.1 Global pharmaceutical industry: planned change in staff recruitment activity by buyers
3.5.2 Global pharmaceutical industry: planned change in staff recruitment activity by suppliers
3.5.3 Global pharmaceutical industry: planned change in staff recruitment activity by region
3.5.4 Global pharmaceutical industry: planned change in staff recruitment activity by company turnover
4 Global Pharmaceutical Industry Market Growth Outlook
4.1 Global Pharmaceutical Industry: Demand in Emerging Markets
4.1.1 Global pharmaceutical industry: demand in emerging markets by buyers
4.1.2 Global pharmaceutical industry: demand in emerging markets by suppliers
4.1.3 Global pharmaceutical industry: demand in emerging markets by region
4.1.4 Global pharmaceutical industry: demand in emerging markets by company turnover
4.2 Global Pharmaceutical Industry: Growth Expectations in Developed Countries
4.2.1 Global pharmaceutical industry: growth expectations in developed countries by buyers
4.2.2 Global pharmaceutical industry: growth expectations in developed countries by suppliers
4.2.3 Global pharmaceutical industry: growth expectations in developed countries by region
4.2.4 Global pharmaceutical industry: growth expectations in developed countries by company turnover
5 Threats and Opportunities for the Global Pharmaceutical Industry
5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2012–2013
5.1.1 Global pharmaceutical industry: leading business concerns for 2012–2013 by company type
5.1.2 Global pharmaceutical industry: leading business concerns for 2012–2013 by region
5.1.3 Global pharmaceutical industry: leading business concerns for 2012–2013 by company turnover
5.2 Global Pharmaceutical Industry: Key Supplier Actions to Secure Buyer Business
5.2.1 Global pharmaceutical industry: key actions to secure buyer business (buyer respondents)
5.2.2 Global pharmaceutical industry: key actions to secure buyer business by region
5.2.3 Global pharmaceutical industry: key actions to secure buyer business by turnover
5.2.4 Global pharmaceutical industry: key actions to secure buyer business by procurement budget
5.2.5 Global pharmaceutical industry: key actions to secure buyer business by purchasing decision authority
6 Pharmaceutical Industry Supplier Marketing Spend Activity
6.1 Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers
6.1.1 Annual marketing budgets by region: global pharmaceutical industry suppliers
6.1.2 Annual marketing budgets by company turnover: global pharmaceutical industry suppliers
6.2 Planned Change in Marketing Expenditure Levels: Global Pharmaceutical Industry Suppliers
6.2.1 Planned change in marketing expenditure by region: global pharmaceutical industry suppliers
6.2.2 Planned change in marketing expenditure by turnover: global pharmaceutical industry suppliers
6.2.3 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2012
6.3 Future Investment by Media Channel: Global Pharmaceutical Industry Suppliers
6.3.1 Future investment by media channel by region: global pharmaceutical industry suppliers
6.3.2 Future investment by media channel by company turnover: global pharmaceutical industry suppliers
6.4 Global Pharmaceutical Industry Suppliers’ Future Investment in Marketing and Sales
6.4.1 Investment in marketing and sales by region: global pharmaceutical industry suppliers
6.4.2 Investment in marketing and sales by region: global pharmaceutical industry suppliers
6.4.3 Investment in marketing and sales by turnover: global pharmaceutical industry suppliers
7 Marketing and Sales Behaviors and Strategies in 2012-2013
7.1 Key Marketing Aims for 2012–2013: Global Pharmaceutical Industry Suppliers
7.1.1 Key marketing aims by region: global pharmaceutical industry suppliers
7.1.2 Key marketing aims by company turnover: global pharmaceutical industry suppliers
7.1.3 Key marketing aims by revenue growth expectations: global pharmaceutical industry suppliers
7.2 Essential Amendments to Marketing Activities in 2012–2013
7.2.1 Amendments to marketing activities by region: global pharmaceutical industry suppliers
7.2.2 Amendments to marketing activities by company turnover: global pharmaceutical industry suppliers
7.3 Use of New Media for Business Prospects: Global Pharmaceutical Industry Suppliers
7.3.1 Use of new media by region: global pharmaceutical industry suppliers
7.3.2 Use of new media by company turnover: global pharmaceutical industry suppliers
7.4 Critical Success Factors for Choosing a Marketing Agency
7.4.1 Critical success factors for choosing a marketing agency by region
7.4.2 Critical success factors for choosing a marketing agency by company turnover: global pharmaceutical industry suppliers
8 Appendix
8.1 Global Pharmaceutical Industry Survey Results – Closed Questions
8.2 Methodology
8.3 Contact us
8.4 About ICD Research
8.5 Disclaimer

List of Tables
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010–2012
Table 9: Global Pharmaceutical Industry Revenue Growth Optimism by Buyers (%), 2010–2012
Table 10: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010–2012
Table 11: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Table 12: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Table 13: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Table 14: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Table 15: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Table 16: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Table 17: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Table 18: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010–2012
Table 19: M&A Projections: Global CRO and CMO (%), 2010–2012
Table 20: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010–2012
Table 21: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Table 22: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Table 23: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Table 24: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Table 25: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Table 26: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Table 27: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Table 28: Staff Recruitment by Global Pharmaceutical Industry Suppliers (%), 2012
Table 29: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Table 30: Global Pharmaceutical Industry Staff Recruitment by Turnover (%), 2012
Table 31: Demand in Emerging Markets by Global Pharmaceutical Manufacturers (%), 2012
Table 32: Demand in Emerging Markets by Global CRO and CMO Industry (%), 2012
Table 33: Demand in Emerging Markets by Global Pharmaceutical Industry Suppliers (%), 2012
Table 34: Growth in Developed Countries: Global Pharmaceutical Manufacturers (%), 2012
Table 35: Growth Expectations in Developed Countries by Global CRO and CMO Respondents(%), 2012
Table 36: Growth Expectations in Developed Countries by Global Pharmaceutical Industry Suppliers (%), 2012
Table 37: Global Pharmaceutical Industry: Leading Concerns (%), 2010–2012
Table 38: Global Pharmaceutical Industry: Leading Business Concerns by Company (%), 2012–2013
Table 39: Global Pharmaceutical Industry: Leading Business Concerns by Region (%), 2012–2013
Table 40: Global Pharmaceutical Industry: Leading Business Concerns by Turnover (%), 2012–2013
Table 41: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2012
Table 42: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2012
Table 43: Actions to Maintain and Secure Buyer Business by Region (%), 2012
Table 44: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2012
Table 45: Actions to Maintain and Secure Buyer Business by Procurement Budget (%), 2012
Table 46: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010–2012
Table 47: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 48: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 49: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010–2012
Table 50: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Table 51: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Table 52: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2012
Table 53: Net Change in Planned Marketing Expenditure, All Industries Comparison (%) 2012
Table 54: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Table 55: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 56: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 57: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 58: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012
Table 59: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 60: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 61: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 62: Use of New Media by Suppliers: Global Pharmaceutical Industry (%),2012
Table 63: Use of New Media by Region: Global Pharmaceutical Industry (%),2012
Table 64: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%),2012
Table 65: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2010–2012
Table 66: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 67: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 68: Survey Results - Closed Questions

List of Figures
Figure 1: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010–2012
Figure 2: Global Pharmaceutical Industry Revenue Growth Optimism by Company Type(%), 2010–2012
Figure 3: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010–2012
Figure 4: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Figure 5: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Figure 6: Revenue Growth Optimism: Cross Industry Comparison (%), 2012
Figure 7: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Figure 8: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Figure 9: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Figure 10: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Figure 11: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Figure 12: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010–2012
Figure 13: M&A Projections: Global CRO and CMO Industry (%), 2010–2012
Figure 14: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010–2012
Figure 15: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Figure 16: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Figure 17: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Figure 18: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Figure 19: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Figure 20: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Figure 21: Global Pharmaceutical Industry Capital Expenditure Forecast by Region (%), 2012
Figure 22: Global Pharmaceutical Industry Capital Expenditure Forecast by Turnover (%), 2012
Figure 23: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Figure 24: Planned Change in Staff Hiring Activities by Pharmaceutical Industry Suppliers (%), 2012
Figure 25: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Figure 26: Planned Change in Staff Hiring Activities by Company Turnover (%), 2012
Figure 27: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2012
Figure 28: Global Pharmaceutical Industry: Top Five Emerging Markets, 2012
Figure 29: Demand in Emerging Markets by Global Pharmaceutical Manufacturers (%), 2012
Figure 30: Demand in Emerging Markets by Global CRO and CMO Industry (%), 2012
Figure 31: Demand in Emerging Markets by Global Pharmaceutical Industry Suppliers (%), 2012
Figure 32: Global Pharmaceutical Industry: Demand in Emerging Markets by Region (%), 2012
Figure 33: Global Pharmaceutical Industry: Demand in Emerging Markets by Turnover (%), 2012
Figure 34: Global Pharmaceutical Industry: Top Five Developed Countries Targeted for Growth, 2012
Figure 35: Growth in Developed Countries: Global Pharmaceutical Manufacturers (%), 2012
Figure 36: Growth Expectations in Developed Countries by Global CRO and CMO Respondents(%), 2012
Figure 37: Growth Expectations in Developed Countries by Global Pharmaceutical Industry Suppliers (%), 2012
Figure 38: Global Pharmaceutical Industry: Growth in Developed Countries by Region (%), 2012
Figure 39: Global Pharmaceutical Industry: Growth Expectations in Developed Countries by Turnover (% 'Increase' Responses), 2012
Figure 40: Global Pharmaceutical Industry: Leading Business Concerns (%), 2012–2013
Figure 41: Global Pharmaceutical Industry: Leading Business Concerns (%), 2012–2013
Figure 42: Global Pharmaceutical Industry: Leading Business Concerns by Company (%), 2012–2013
Figure 43: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2012
Figure 44: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2012
Figure 45: Actions to Maintain and Secure Buyer Business by Company Region (%), 2012
Figure 46: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2012
Figure 47: Actions to Maintain and Secure Buyer Business by Purchasing Decision Authority (%), 2012
Figure 48: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010–2012
Figure 49: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 50: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 51: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010–2012
Figure 52: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Figure 53: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Figure 54: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Figure 55: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Region (%), 2012
Figure 56: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Turnover (%), 2012
Figure 57: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 58: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 59: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 60: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 61: Key Marketing Aims by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 62: Key Marketing Aims by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 63: Key Marketing Aims by Revenue Growth Expectations: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 64: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 65: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 66: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 67: Use of New Media by Suppliers: Global Pharmaceutical Industry (%), 2012
Figure 68: Use of New Media by Region: Global Pharmaceutical Industry (%), 2012
Figure 69: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%), 2012
Figure 70: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 71: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 72: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

- Sanofi Aventis
- Gen-Probe Incorporated
- Neumedicines
- RxBio
- Araim Pharmaceuticals of Ossining and Cellerant Therapeutics
- Pfizer
- Tibet Pharmaceuticals
- Anhui Taihe Pharmaceutical Group
- BioMarin Pharmaceutical
- Abbott
- Catalent Pharma Solutions
- Vitamin Shoppe
- OncoSec Medical
- Quintiles
- QPS
- Neptune Technologies and Bioressources
- Sartorius Stedim Biotech
- Bosch Packaging Technology
- Sanner
- Bristol-Myers Squibb
- Micromet
- Amgen
- OPKO Health USA
- ALS Distribuidora Limitada
- UCB Pharma
- Astellas Pharma Inc
- UCB Pharmaand Nodality
- INC Research LLC
- Trident Clinical Research
- Accelrys
- VelQuest
- Indoco Remedies
- DSM
- Mylan Inc
- Johnson & Johnson
- J.B. Chemicals & Pharmaceuticals
- Watson Pharmaceuticals
- Ascent Pharmahealth
- Strides Arcolab
- Sigma-Aldrich
- BioReliance
- Takeda Pharmaceutical Company Ltd
- Teva Pharmaceuticals
- Sinopharm
- Yunnan Baiyao Group Co Ltd
- Zhangzhou Pientzehuang Pharmaceutical Co Ltd
- Jiangsu Hengruli Medicine Co Ltd
- Celesio
- Bergamo
- Ranbaxy Labs
- Daiichi Sankyo
- Matrix Lab
- Dabur Pharma
- Fresenius Kabi
- Shanta Biotech
- Orchid Chemicals
- Hospira
- Piramal Healthcare
- Wuxi PharmaTech
- AstraZenecahas
- SOTAX
- Baxter
- GlaxoSmithKline
- Lonza
- Roche
- ASAN Medical Center
- Anosmatic Corporation
- Chesapeake Pharmaceutical and Healthcare Packaging
- Orkut
- Twitter
- Facebook
- LinkedIn
- PatientsLikeMe
- DailyStrength
- Google
- Yahoo
- Bing
- Allergan Inc
- MySpace
- YouTube
- Flickr.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos